Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Shun KanekoYasuhiro AsahinaMiyako MurakawaShunsuke UeyamaChiaki MaeyashikiHideki WatanabeAkiko Kusano-KitazumeAyako SatoKozue UchidateTakehito AsakawaSho WatanabeYasuhiro IizukaIsamu ShibataShinya OookaYuko KarakamaTakashi FujiiTaro WatabeKeiichi AkahoshiMinoru TanabeKento InadaTomohiro MochidaKeiya WatakabeTaro ShimizuJun TsuchiyaMasato MiyoshiFukiko Kitahata-KawaiSayuri NittaMina NakagawaSei KakinumaRyuichi Okamotonull null

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)

CRP was a significant biomarker in patients treated with ATZ + BEV for HCC. Elevated CRP levels may indicate aggressive cancer progression and potential resistance to ATZ + BEV therapy.

Keyphrases

papillary thyroid
squamous cell
locally advanced
metastatic colorectal cancer
lymph node metastasis
liver metastases
childhood cancer
squamous cell carcinoma
human health
mesenchymal stem cells
newly diagnosed
cell therapy
rectal cancer
replacement therapy